Disclosure Panels Details Page
Cervical/Uterine Cancers Panel - Disclosures as of 06/30/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Nadeem Abu-Rustum MD | GRAIL | NCCN | None | None | 03/12/2024 |
| Rebecca Arend MD | Artera Champions Oncology, Inc. Exelixis Inc. Faeth Therapeutics ImmunoGen, Inc. LEAP Therapeutics LifeNet Merck & Co., Inc. Regeneron Pharmaceuticals, Inc. |
AstraZeneca Pharmaceuticals LP | None | None | 05/01/2024 |
| Emma Barber MD | Eli Lilly and Company | Merck & Co., Inc. | None | None | 05/09/2024 |
| Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| Kristin Bradley MD | None | None | None | American Brachytherapy Society|UpToDate, contributing author | 04/07/2024 |
| Rebecca Brooks MD | None | None | ABOG AstraZeneca Pharmaceuticals LP Curio Science Eisai Inc. GSK MedLogix |
Steering Committee for IQVIA NRG GY 3035 clinical trial | 06/08/2024 |
| Susana Campos MS,MPH,MD | None | AstraZeneca Pharmaceuticals LP Daiichi- Sankyo Co. Eisai Inc. GSK ImmunoGen, Inc. Merck & Co., Inc. |
None | None | 05/18/2024 |
| Junzo Chino MD | KM Pharmaceutical Consulting LLC | Merck & Co., Inc. | Stryker | None | 02/12/2024 |
| Hye Sook Chon MD | None | Clinical Care Options Eisai Inc. |
None | None | 02/23/2024 |
| Marta Ann Crispens MD | None | None | None | None | 04/05/2024 |
| Shari Damast MD | MyCareGorithm | None | None | None | 05/02/2024 |
| Christine Fisher MD,MPH | Vail Health Shaw Cancer Center | None | None | None | 06/17/2024 |
| Peter Frederick MD | None | None | None | None | 04/26/2024 |
| David Gaffney PhD,MD | Elekta | Merck & Co., Inc. | None | Co-Chair, Gyn Committee, NRG Oncology | 01/14/2024 |
| Stephanie Gaillard PhD,MD | AstraZeneca Pharmaceuticals LP Blueprint Medicines Clovis Oncology Compugen GSK ImmunoGen, Inc. SignPath Pharma Tempest Volastra |
Organon Verastem |
None | None | 04/17/2024 |
| Robert Giuntoli II MD | AstraZeneca Pharmaceuticals LP | Buckingham, Doolittle & Burroughs, LLC Eckert Seamans Cherin & Mellott, LLC Kolsby, Gordon, Robin & Shore PC Rawle & Henderson, LLP Roetzel & Andress |
None | None | 01/10/2024 |
| Scott Glaser MD | Aiden Industries | None | None | None | 03/25/2024 |
| Kristina Gregory MSN,RN | None | None | None | None | 05/27/2024 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 06/18/2024 |
| Erin Hesler | None | None | None | None | 05/08/2024 |
| Brooke Howitt MD | None | Cartography Biosciences Santa Ana Bio Tempus |
None | None | 02/16/2024 |
| Kari Kendra PhD,MD | Bristol Myers Squibb GSK Immunocore Melanoma Research Foundation Merck & Co., Inc. National Institute on Aging Regeneron Pharmaceuticals, Inc. Varian Medical Systems |
None | None | None | 05/09/2024 |
| Lisa Landrum MD,PhD | None | GSK | None | None | 02/03/2024 |
| Jayanthi Lea MD | None | AstraZeneca Pharmaceuticals LP | None | None | 03/29/2024 |
| Nita Lee MD,MPH | None | Cancer Support Community National Ovarian Cancer Coalition |
None | None | 05/23/2024 |
| Gina Mantia-Smaldone MD | None | None | None | None | 04/21/2024 |
| Andrea Mariani MD | None | None | None | None | 05/17/2024 |
| Nicole McMillian MS | None | None | None | None | 04/22/2024 |
| David Mutch MD | None | None | None | None | 02/10/2024 |
| Christa Nagel MD | None | None | None | None | 04/01/2024 |
| Larissa Nekhlyudov MD,MPH | None | None | None | None | 04/29/2024 |
| Karina Nieto MD | None | None | None | None | 01/16/2024 |
| Sharon Park PharmD,BCOP | None | None | None | None | 02/09/2024 |
| Mirna Podoll MD | None | None | None | None | 06/18/2024 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Kerry Rodabaugh MD | None | None | None | None | 04/30/2024 |
| Ritu Salani MBA,MD | Merck & Co., Inc. Nykode Therapeutics |
Eisai Inc. GSK Karyopharm Therapeutics Merck & Co., Inc. SeaGen |
None | Elsevier|UpToDate | 05/27/2024 |
| Vaishnavi Sambandam PhD | None | None | None | None | 02/06/2024 |
| John Schorge MD | None | None | None | None | 02/12/2024 |
| Scott Schuetze PhD,MD | Adaptimmune Advenchen Ayala Pharmaceuticals BioAtla Boehringer Ingelheim GmbH Cogent Biosciences, Inc Epizyme GSK Inhibrx, Inc Pfizer Inc. Pharma Mar Polaris Pharmaceuticals PTC Therapeutics, Inc RAIN Therapeutics Shanghai Pharmaceuticals TRACON Pharmaceuticals, Inc. |
None | None | UpToDate | 05/17/2024 |
| Jean Siedel MS,DO | None | None | None | None | 05/14/2024 |
| Rachel Sisodia MD | None | None | None | None | 05/30/2023 |
| Pamela Soliman MPH,MD | GSK Leap Therapeutics Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
Expert Perspectives® in Endometrial Cancer GSK Medscape |
None | None | 04/11/2024 |
| Stefanie Ueda MD | None | None | None | None | 02/13/2024 |
| Renata Urban MD | None | None | Clinical Care Options, Inc. | Royalties received as author, UpToDate, Inc. | 05/14/2024 |
| Erin Vidic | None | None | None | None | 05/31/2024 |
| Amanda Visnick OCN,RN,BSN | None | None | None | None | 04/12/2024 |
| Emily Wyse | None | None | None | None | 06/26/2024 |